South Africa /
The vaccine Johnson & Johnson against covid-19 has a Overall efficiency of 66%, although less so in South Africa, where a variant of the most contagious coronavirusThe US pharmaceutical company announced in a statement on Friday.
The vaccine, which requires a single injection, is effective in one 85% for the prevention of severe forms of the disease, according to an extensive clinical study.
It’s to be expected Johnson & Johnson Apply for an emergency distribution authorization in the United States starting next week.
Two vaccines against covid-19 are currently in circulation in the country that adds the most deaths due to the pandemic: that of Modern and Pfizer-BioNTech.
The potential amount of a third comes at a time when the United States is trying to speed up its immunization rate to meet the new president’s goal, Joe Biden, 1.5 million doses injected daily.
The group has promised to send 100 million doses in the United States before the end of June, a few 200 million doses to the European Union before the end of the year, with the first shipments in April and another 200 million to developing countries, starting in June.
Like vaccines Pfizer and Moderna, The “J&J” immunizer sends genetic instructions to the cells of the human body to create a protein specific to coronavirus, which in turn allows the immune system to be trained to respond appropriately to the true virus.
Easy distribution
The vaccine Johnson & Johnson it can however be kept at normal refrigerator temperatures and not in freezers, which facilitates its distribution.
(…)